Sezerol Mehmet Akif, Davun Selin
Doctorate Program, Institute of Health Sciences Epidemiology, Medipol University, Istanbul 34810, Turkey.
Health Management Program, Graduate Education Institute, Maltepe University, Istanbul 34857, Turkey.
Vaccines (Basel). 2023 Jan 5;11(1):132. doi: 10.3390/vaccines11010132.
The COVID-19 virus appeared in Wuhan, China in 2019 and spread rapidly all over the world. Vaccination guidelines have recommended pregnant women to get vaccinated against COVID-19 to prevent disease. This study aimed to understand the willingness of pregnant women to vaccinate and the factors associated with their hesitation and resistance. This cross-sectional study was conducted between March and April 2022. The sample size was not calculated and tried to reach all pregnant women who did not have any COVID-19 vaccine. In the first part of the questionnaire, socio-demographic questions, and in the last part, the short form of the 12-item anti-vaccine scale, which was prepared as a 5-point Likert scale, were applied. The study was completed with 561 pregnant women. The mean score of the pregnant women who participated in this study from the vaccine hesitancy scale was found to be 33.40 ± 6.07. It was found that as the income of pregnant women decreased, the vaccine hesitancy scores decreased. Vaccine hesitancy scores of those who stated no one gave advice were significantly higher. The vaccination of pregnant women will bring significant success to the fight against the COVID-19 pandemic when implemented as part of the public health policies of countries.
2019年，新型冠状病毒肺炎病毒在中国武汉出现，并迅速蔓延至全球。疫苗接种指南建议孕妇接种新冠疫苗以预防疾病。本研究旨在了解孕妇的接种意愿以及与她们犹豫和抵触相关的因素。这项横断面研究于2022年3月至4月进行。样本量未进行计算，试图涵盖所有未接种过任何新冠疫苗的孕妇。在问卷的第一部分，设置了社会人口学问题，在最后部分，应用了作为5点李克特量表编制的12项反疫苗量表的简版。该研究共纳入561名孕妇。参与本研究的孕妇在疫苗犹豫量表上的平均得分为33.40±6.07。研究发现，随着孕妇收入降低，疫苗犹豫得分也降低。表示无人给予建议的孕妇的疫苗犹豫得分显著更高。当作为各国公共卫生政策的一部分实施时，孕妇接种疫苗将为抗击新冠疫情带来显著成效。
